Singapore Markets closed
Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) BTC-USD
67,911.52 +2,169.88 (+3.30%) CMC Crypto 200
1,374.92 +44.31 (+3.33%)
UroGen Pharma Ltd. (0XOD.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 04:38PM BST
| Previous close | 16.73 |
| Open | 16.53 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 16.38 - 16.53 |
| 52-week range | 7.83 - 24.01 |
| Volume | |
| Avg. volume | 457 |
| Market cap | 229.162M |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Wall Street Analysts See a 149.01% Upside in Urogen Pharma (URGN): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 149% in Urogen Pharma (URGN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- Zacks
Urogen Pharma (URGN) Surges 9.7%: Is This an Indication of Further Gains?
Urogen Pharma (URGN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- Simply Wall St.
UroGen Pharma First Quarter 2024 Earnings: Misses Expectations
UroGen Pharma ( NASDAQ:URGN ) First Quarter 2024 Results Key Financial Results Revenue: US$18.8m (up 9.2% from 1Q...
© 2024 Yahoo. All rights reserved.